Oncoinvent ASA (KLDVK) — Cash Flow-to-Debt Ratio
Oncoinvent ASA (KLDVK) has a Cash Flow-to-Debt Ratio of 0.02x as of December 2025, meaning its operating cash flow of Nkr3.64 Million could theoretically repay 0% of its total liabilities (Nkr230.30 Million) in one year. See how much free cash does Oncoinvent ASA generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Oncoinvent ASA Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for Oncoinvent ASA across 5 annual periods. Also explore Oncoinvent ASA (KLDVK) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Oncoinvent ASA (2021–2025)
Year-by-year debt coverage analysis for Oncoinvent ASA. For market capitalisation and broader financial context, see KLDVK stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (NOK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.10x | Nkr-23.24 Million | Nkr230.30 Million | ▼ -46.0% |
| 2024 | -0.07x | Nkr-14.84 Million | Nkr214.71 Million | ▲ +75.3% |
| 2023 | -0.28x | Nkr-40.23 Million | Nkr143.77 Million | ▼ -9065.0% |
| 2022 | 0.00x | Nkr373.06K | Nkr119.51 Million | ▲ +41.6% |
| 2021 | 0.00x | Nkr130.66K | Nkr59.25 Million | — |